Varian Medical Systems, Inc. (NYSE:VAR) – Research analysts at Barrington Research increased their Q4 2017 earnings per share estimates for shares of Varian Medical Systems in a research note issued on Thursday. Barrington Research analyst M. Petusky now expects that the medical equipment provider will post earnings per share of $1.17 for the quarter, up from their prior estimate of $1.12. Barrington Research currently has a “Market Perform” rating on the stock.

Varian Medical Systems (NYSE:VAR) last released its earnings results on Wednesday, July 26th. The medical equipment provider reported $1.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.09. Varian Medical Systems had a return on equity of 24.70% and a net margin of 9.50%. The business had revenue of $662.40 million for the quarter, compared to analyst estimates of $663.86 million. During the same quarter in the prior year, the company posted $1.00 earnings per share. Varian Medical Systems’s revenue was up 3.0% on a year-over-year basis. ILLEGAL ACTIVITY WARNING: This piece was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another publication, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/08/10/q4-2017-earnings-estimate-for-varian-medical-systems-inc-issued-by-barrington-research-var-updated.html.

Other equities analysts also recently issued research reports about the company. TheStreet upgraded Varian Medical Systems from a “c+” rating to a “b+” rating in a research note on Wednesday, April 26th. Citigroup Inc. upgraded Varian Medical Systems from a “neutral” rating to a “buy” rating in a research note on Monday, May 15th. Jefferies Group LLC restated a “buy” rating on shares of Varian Medical Systems in a research note on Thursday, May 11th. BTIG Research upgraded Varian Medical Systems from a “neutral” rating to a “buy” rating and set a $106.00 target price on the stock in a research note on Monday, May 8th. Finally, BidaskClub downgraded Varian Medical Systems from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, June 14th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and four have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $96.28.

In other Varian Medical Systems news, EVP Kolleen T. Kennedy sold 1,088 shares of the business’s stock in a transaction on Wednesday, July 12th. The shares were sold at an average price of $104.49, for a total transaction of $113,685.12. Following the sale, the executive vice president now owns 27,688 shares of the company’s stock, valued at approximately $2,893,119.12. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Timothy E. Guertin sold 16,000 shares of the business’s stock in a transaction on Friday, June 9th. The shares were sold at an average price of $103.22, for a total transaction of $1,651,520.00. Following the sale, the director now directly owns 2,161 shares in the company, valued at approximately $223,058.42. The disclosure for this sale can be found here. Insiders sold a total of 147,676 shares of company stock worth $14,979,214 in the last ninety days. 0.91% of the stock is currently owned by insiders.

Large investors have recently modified their holdings of the stock. Speece Thorson Capital Group Inc. boosted its stake in shares of Varian Medical Systems by 0.5% in the second quarter. Speece Thorson Capital Group Inc. now owns 123,055 shares of the medical equipment provider’s stock worth $12,698,000 after buying an additional 558 shares during the last quarter. Deroy & Devereaux Private Investment Counsel Inc. acquired a new stake in shares of Varian Medical Systems during the second quarter worth about $206,000. Park Avenue Securities LLC boosted its stake in shares of Varian Medical Systems by 0.4% in the second quarter. Park Avenue Securities LLC now owns 2,276 shares of the medical equipment provider’s stock worth $234,000 after buying an additional 9 shares during the last quarter. FineMark National Bank & Trust boosted its stake in shares of Varian Medical Systems by 142.2% in the second quarter. FineMark National Bank & Trust now owns 5,744 shares of the medical equipment provider’s stock worth $593,000 after buying an additional 3,372 shares during the last quarter. Finally, Parkwood LLC acquired a new stake in shares of Varian Medical Systems during the second quarter worth about $437,000. 99.64% of the stock is currently owned by institutional investors and hedge funds.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Earnings History and Estimates for Varian Medical Systems (NYSE:VAR)

Receive News & Stock Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related stocks with our FREE daily email newsletter.